Volume : 10, Issue : 06, June – 2023

Title:

23.FORMULATION AND DEVELOPMENT OF TRANSFEROSOMAL GEL INCORPORATING WITH CHRYSIN FOR TOPICAL APPLICATION

Authors :

Madhulika*, Dr. Manish Kumar Gupta

Abstract :

Skin infection have variable presentations, etiologies and severities. Among the numerous drug delivery systems, vesicles as a drug carrier system have emerged as the preferred vehicle. Transfersomes have been discovered to be one of the most effective drug-delivery methods for topical treatment when compared to conventional topical systems. So, in this study, with the use of a gelling agent as a vehicle for the inclusion of transfersomes the transferosomal gel of chrysin was created for topical administration system. Preparation & evaluation of transferosomal gel was performed as per standard method. Results showed that F-12 formulation have lowest vesicle size of 165.58% with & entrapment efficiency of 73.49%. The zeta potential for F12 was recorded as -38.85. Further, the result of evaluation of transferosomal gel suggested that the optimized gel OTGF1 have Extrudability (g) and Spreadability (g.cm/sec) as 185±2.5 g and 11.15±1.5 g.cm/sec respectively. The viscosity of gel was noted to be 3215±18 cps. The % assay for transferosomal gel was estimated to be 98.15±0.32%. The % Cumulative Drug Release was found to be 92.23 at 12hour. Also, the formulated transferosomal gel was found to be stable for 3 months at 4.0 ±0. 2°C with normal physical appearance & drug content of 95.58&%.
Keywords: Skin infection, Topical drug deliver, Novel drug delivery system Transferosome, Transferososmal gel

Cite This Article:

Please cite this article in press Seba M C et al, Formulation And Development Of Transferosomal Gel Incorporating With Chrysin For Topical Application., Indo Am. J. P. Sci, 2023; 10 (06).

Number of Downloads : 10

References:

1. Ki V, Rotstein C. Bacterial skin and soft tissue infections in adults: a review of their epidemiology, pathogenesis, diagnosis, treatment and site of care. Canadian Journal of Infectious Diseases and Medical Microbiology. 2008 Mar 1;19(2):173-84.
2. Sukumaran V, Senanayake S. Bacterial skin and soft tissue infections. Australian prescriber. 2016 Oct;39(5):159.
3. Kumar KS, Bhowmik D, Srivastava S, Paswan S, Dutta AS. Sustained release drug delivery system potential. The pharma innovation. 2012 Apr 1;1(2).
4. Sercombe L, Veerati T, Moheimani F, Wu SY, Sood AK, Hua S. Advances and challenges of liposome assisted drug delivery. Frontiers in pharmacology. 2015 Dec 1;6:286.
5. Tanwar H, Sachdeva R. Transdermal drug delivery system: A review. International journal of pharmaceutical sciences and research. 2016 Jun 1;7(6):2274.
6. Wokovich AM, Prodduturi S, Doub WH, Hussain AS, Buhse LF. Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute. European Journal of Pharmaceutics and Biopharmaceutics. 2006 Aug 1;64(1):1-8.
7. Jangme CM, Chavan DV. A review on transferosome: is a boon to human life. International Research Journal of Pharmaceutical and Applied Sciences. 2013 Apr 30;3(2):174-9.
8. Thakur N, Jain P, Jain V. Formulation development and evaluation of transferosomal gel. Journal of Drug Delivery and Therapeutics. 2018 Sep 15;8(5):168-77.
9. Mani R, Natesan V. Chrysin: Sources, beneficial pharmacological activities, and molecular mechanism of action. Phytochemistry. 2018 Jan 1;145:187-96.
10. Malakar J, Sen SO, Nayak AK, Sen KK. Formulation, optimization and evaluation of transferosomal gel for transdermal insulin delivery. Saudi pharmaceutical journal. 2012 Oct 1;20(4):355-63.
11. Ghanbarzadeh S, Arami S. Enhanced transdermal delivery of diclofenac sodium via conventional liposomes, ethosomes, and transfersomes. BioMed research international. 2013 Oct;2013.
12. Qushawy M, Nasr A, Abd-Alhaseeb M, Swidan S. Design, optimization and characterization of a transfersomal gel using miconazole nitrate for the treatment of candida skin infections. Pharmaceutics. 2018 Feb 23;10(1):26.
13. Sharma A, Dubey A, Gupta P, Yadav R, Saraogi R. Transferosome: novel drug delivery system. International Journal of Biological & Pharmaceutical Research. 2012;3(5):722-8.
14. Jivrani SD, Patel VK. formulation, development and evaluation of niosomal drug delivery system for clindamycin phosphate. Pharma Science Monitor. 2014 Apr 2;5.